Kabra Drugs Ltd.
BSE: 524322 | Sector: Health care |
NSE: N.A. | ISIN Code: INE323K01017 |
BSE 00:00 | 27 Jan | 4.18 |
-0.22 (-5.00%) |
OPEN
4.50 |
HIGH
4.50 |
LOW
4.18 |
NSE 05:30 | 01 Jan | Kabra Drugs Ltd |
OPEN | 4.50 |
PREVIOUS CLOSE | 4.40 |
VOLUME | 205 |
52-Week high | 5.70 |
52-Week low | 2.95 |
P/E | |
Mkt Cap.(Rs cr) | 2 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Kabra Drugs Ltd. (KABRADRUGS) - Profit And Loss
Figures in Rs crore | 2022 | 2021 | 2020 |
Income | |||
Sales Turnover | 0.00 | 0.00 | 0.00 |
Excise Duty | 0.00 | 0.00 | 0.00 |
Net Sales | 0.00 | 0.00 | 0.00 |
Other Income | 0.00 | 0.00 | 0.02 |
Stock Adjustments | 0.00 | 0.00 | 0.00 |
Total Income | 0.00 | 0.00 | 0.02 |
Expenditure | |||
Raw Materials | 0.00 | 0.00 | 0.00 |
Power & Fuel Cost | 0.00 | 0.00 | 0.00 |
Employee Cost | 0.09 | 0.05 | 0.00 |
Other Manufacturing Expenses | 0.00 | 0.00 | 0.00 |
Selling and Administration Expenses | 0.08 | 0.10 | 0.05 |
Miscellaneous Expenses | 0.01 | 0.00 | 0.00 |
less: Pre-operative Expenses Capitalised | 0.00 | 0.00 | 0.00 |
Total Expenditure | 0.18 | 0.15 | 0.05 |
Operating Profit | -0.18 | -0.15 | -0.03 |
Interest | 0.00 | 0.00 | 0.00 |
Gross Profit | -0.18 | -0.15 | -0.03 |
Depreciation | 0.01 | 0.03 | 0.03 |
Profit Before Tax | -0.19 | -0.18 | -0.06 |
Tax | 0.00 | 0.00 | 0.00 |
Net Profit | -0.19 | -0.18 | -0.06 |
Quick Links for Kabra Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices